← All trials
NCT01357759
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2013
- Primary completion
- Jul 1, 2014
- Completion date
- Jul 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- MorphotekLead sponsor
- Altoona Center for Clinical ResearchOverall official - principal investigator
- Seaview Jacksonville, LLCOverall official - principal investigator
- Lynn Health Science InstituteOverall official - principal investigator
- AXIS Clinicals LimitedOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.